TH95774A - Liquid pharmaceutical formulation of 4 - [((4-carboxybutyl) - {2 - [(4-fenethylbenzyl) oxy] fennethyl} amino) methyl] Benzoic acid - Google Patents
Liquid pharmaceutical formulation of 4 - [((4-carboxybutyl) - {2 - [(4-fenethylbenzyl) oxy] fennethyl} amino) methyl] Benzoic acidInfo
- Publication number
- TH95774A TH95774A TH701003324A TH0701003324A TH95774A TH 95774 A TH95774 A TH 95774A TH 701003324 A TH701003324 A TH 701003324A TH 0701003324 A TH0701003324 A TH 0701003324A TH 95774 A TH95774 A TH 95774A
- Authority
- TH
- Thailand
- Prior art keywords
- amino
- pharmaceutical formulation
- carboxybutyl
- oxy
- methyl
- Prior art date
Links
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 title claims abstract 12
- -1 4-carboxybutyl Chemical group 0.000 title claims abstract 7
- 239000007788 liquid Substances 0.000 title claims abstract 7
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract 7
- 239000005711 Benzoic acid Substances 0.000 title claims abstract 6
- 235000010233 benzoic acid Nutrition 0.000 title claims abstract 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title claims abstract 6
- 150000003839 salts Chemical class 0.000 claims abstract 4
- 239000003814 drug Substances 0.000 claims abstract 3
- 229940079593 drug Drugs 0.000 claims abstract 3
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 3
- 229940125904 compound 1 Drugs 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract 2
Abstract
DC60 (03/09/51) การประดิษฐ์นี้เกี่ยวข้องกับสูตรผสมทางเภสัชกรรมชนิดน้ำ ซึ่งประกอบด้วย 4- [((4-คาร์บอกซีบิวทิล)-{2-[(4-เฟนเนทธิลเบนซิล)ออกซี]เฟนเนทธิล}อะมิโน)เมทธิล]เบนโซอิคแอ ซิด หรือเกลือของสารนี้ การประดิษฐ์นี้เกี่ยวข้องโดยเฉพาะอย่างยิ่งกับสูตรผสมทางเภสัชกรรมชนิด น้ำ ซึ่งประกอบ 4-[((4-คาร์บอกซีบิวทิล)-{2-[(4-เฟนเนทธิลเบนซิล)ออกซี]เฟนเนทธิล}อะมิ โน)เมทธิล]เบนโซอิคแอซิด และ 2-อะมิโน-2-(ไฮดรอกซีเมทธิล)-1,3-โปรเปนไดออล (โทรเมททา มอล) การประดิษฐ์นี้เกี่ยวข้องกับสูตรผสมทางเภสัชกรรมชนิดน้ำ ซึ่งประกอบด้วย 4- [((4-คาร์บอกซีบิวทิล)-{2-[(4-เฟเนทธิลเบนซิล)ออกซี]เฟนเนทธิล}อะมิโน)เมทธิล]เบนโซอิคแอ ซิด หรือเกลือของสารนี้ การประดิษฐ์นี้เกี่ยวข้องโดยเฉพาะอย่างยิ่งกับสูตรผสมทางเภสัชกรรมชนิด น้ำ ซึ่งประกอบ 4-[((4-คาร์บอกซีบิวทิล)-{2-[(4-เฟนเนทธิลเบนซิล)ออกซี]เฟนเนทธิล}อะมิ โน)เมทธิล]เบนโซอิคแอซิด และ 2-อะมิโน-2-(ไฮดรอกซีเมทธิล)-1,3-โปรเปนไดออล (โทรเมททา มอล) สิทธิบัตรยา DC60 (03/09/51) This invention involves a liquid pharmaceutical formulation. Which consists of 4- [((4-carboxybutyl) - {2 - [(4- fenethylbenzyl) oxy] fennethyl} amino) methyl. L] benzoic acid or salt of this substance. This invention is particularly relevant to a liquid pharmaceutical formulation consisting of 4 - ((4-carboxybutyl) - (2 - ((4-fenethylbenzyl)). Oxy] fennethyl} ami No) methyl) benzoic acid and 2-amino-2- (hydroxymethyl) -1,3-propendiol (tromethamol). This invention involves a liquid pharmaceutical formulation. Which consists of 4- [((4-carboxybutyl) - {2 - [(4- phenethylbenzyl) oxy] fennethyl} amino) methyl. ] Benzoic acid or salt of this substance. This invention is particularly relevant to a liquid pharmaceutical formulation consisting of 4 - ((4-carboxybutyl) - (2 - ((4-fenethylbenzyl)). Oxy] fennethyl} ami No) methyl] benzoic acid and 2-amino-2- (hydroxymethyl) -1,3-propendyl (tromethamol) patent. drug
Claims (3)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH95774A true TH95774A (en) | 2009-05-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201070698A1 (en) | SOLID FORMS OF 3- (6- (1- (2,2-DIFTLOROXENO [D] [1,3] -DIOXOL-5-IL) CYCLOPROPANKARAROXAMIDO) -3-METHYLPYRIDIN-2-IL) Benzoic Acid | |
| AR104566A2 (en) | CRYSTAL FORM OF SALT DICHLORHYDRATE OF ((1S) -1 - (((2S) -2- (5- (4- (2 - ((2S) -1 - ((2S) -2 - ((METOXICARBONIL) AMINO ) -3-METHYLBUTANOIL) -2-PIRROLIDINIL) -1H-IMIDAZOL-5-IL) -4-BIFENILIL) -1H-IMIDAZOL-2-IL) -1-PIRROLIDINIL) CARBONIL) -2-METHYLPROPIL) METHYL CARBAMATE | |
| IL186435A (en) | Oral pharmaceutical formulation comprising choline salt of 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propanoic acid | |
| PT1937065E (en) | NEW LYSINE SALTS OF DERIVATIVES ACID 4 - ((PHENOXIALQUIL) TIO) -FENOXIACÉTICO | |
| EA200401136A1 (en) | DESIGNED TO OVERVIEW ONE | |
| AR051735A1 (en) | PIRROLIC INHIBITORS OF THE PROTEIN QUINASA ERK, SYNTHESIS AND INTERMEDIARIES OF THE SAME. | |
| EP2094118A4 (en) | IMPROVED COMPOSITION OF PERACETIC ACID | |
| EP2578574A4 (en) | OPTICALLY ACTIVE DIBENZYLAMINE DERIVATIVE AND PROCESS FOR PREPARING THE SAME | |
| EA200600879A1 (en) | TETRASOLE DERIVATIVES AND METHODS OF TREATMENT OF DISORDERS RELATED TO METABOLISM WITH THEIR HELP | |
| UA94955C2 (en) | Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid | |
| EP2152292A4 (en) | ANGIOGENESIS INHIBITOR COMPRISING METEORIN AS ACTIVE INGREDIENT | |
| TH95774A (en) | Liquid pharmaceutical formulation of 4 - [((4-carboxybutyl) - {2 - [(4-fenethylbenzyl) oxy] fennethyl} amino) methyl] Benzoic acid | |
| ATE526963T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN-MEDOXOMIL | |
| EP1961751A4 (en) | ACID ADDITION SALT OF OPTICALLY ACTIVE DIHYDROPYRIDINE DERIVATIVE | |
| EP1788083A4 (en) | METHOD FOR ASSESSING SENSITIVITY TO A MEDICINAL AS A CDK4 INHIBITOR | |
| BR112012013723A2 (en) | "use of at least one compound of formula (i), method for preserving a cosmetic, dermatological or pharmaceutical composition and cosmetic, dermatological or pharmaceutical composition" | |
| TH81758A (en) | Salts of Carboxylic Acid Derivatives useful in Pharmacy | |
| TH130271A (en) | It is used for the treatment of new diseases of 4- [2- (4-methylphenyl sulfanyl) phenyl] piperidine | |
| TH87765A (en) | Therapeutic agents | |
| TH114612A (en) | Liquid formulation of 4- [2- (4-methylphenyl sulfanyl) phenyl] piperidine salts. | |
| RU2006135431A (en) | METHOD FOR INCREASING THE LEVEL OF PERFORMANCE IN LABORATORY ANIMALS IN THE EXPERIMENT | |
| TH102747A (en) | Crystal form of methyl salt ((1S) -1 - (((2S) -2- (5- (4 '- (2 - (2S) -1 - ((2S) -2 - ((methoxycarbonyl)) a. Mino) -3-methyl butanoil) -2-pyrolidinyl) -1H-imidazol -5-il) -4-biphenyl) -1H -Imidazol-2-il) -1-pyrolidinyl) carbonyl) -2-methylpropyl) carbamate Dihydrochloride | |
| TH96575A (en) | HIV protease inhibitors type 2- (substitutated-amino) -benzothiazole sulfonamides | |
| TH70363A (en) | Process for salt preparation of 5 - ((R) -2 (5,6-Diethyl-Indan-2-ilamino) -1-hydroxy-ethyl) -8-hydroxy- ( 1H) -quinnolin-2-transfer Used as an agonist of the adrenoseceptor | |
| TH123699A (en) | Compounds 4- [2- (2-fluorophenoximethyl) phenyl] piperidine |